中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.    京ICP备10007676号-1   Powered by Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173           


Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613547
Marketing: 010-59613639
Medical support: 010-57864983


400 :4001899806


R & D Overview
Page view:

  A strong scientific research team is the core of enterprise innovation. Since its inception, Minhai has established a backbone R & D team to develop its own innovative vaccine technology. It is because there is such a group of talents with ideals, aspirations and national sentiments that have opened up the sea of people today.

The R & D center has an area of 3,900 square meters, including a purification area of 2,200 square meters. It has a 300L fermentation tank, a 35L bioreactor and various purification and verification equipment. , Pilot scale-up and quality assessment.


  R & D team:

There are more than 100 full-time R & D personnel, of which a number of core technical personnel are responsible for or participate in a number of "863" national key research projects and major special projects of the Ministry of Science and Technology (27.6% of masters and above), and have obtained 17 national invention patents.
R & D platform:
1. The combination of applied research results and engineering technology transformation
2. Combining industry, university and research with independent innovation
                               3. The combination of talent management and talent incentives